EMBC 12.73 (+3.66%)
US29082K1051Drug ManufacturersDrug Manufacturers - Specialty & Generic

Embecta (EMBC) Competitor Comparison

We are evaluating the key criteria listed to compare Embecta (EMBC) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 5 years - EMBC ranking 35 / 54

These are the competitors of Embecta in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 5 years
1. Green Thumb Industries R9U2.F
42.27
2. Linc LNC
37.06
3. ProPhase Labs PRPH
32.25
4. Avadel Pharmaceuticals AVDL
30.17
5. Catalent CTLT
20.24
6. Alvotech ALVO
15.66
7. Kamada KMDA
15.01
8. Phibro Animal Health PAHC
13.17
9. Amphastar Pharmaceuticals AMPH
10.66
10. Zoetis ZTS
10.02
11. Neoleukin Therapeutics NLTX
8.58
12. Alimera Sciences ALIM
7.82
13. Cumberland Pharmaceuticals CPIX
7.55
14. Organogenesis Holdings ORGO
7.33
15. Vifor Pharma G2AB.F
7.23
16. Curaleaf Holdings CURLF
6.97
17. Collegium Pharmaceutical COLL
6.92
18. Pacira BioSciences PCRX
6.79
19. PetIQ PETQ
6.43
20. Supernus Pharmaceuticals SUPN
5.23
21. Kolinpharma KIP.MI
4.88
22. Elanco Animal Health ELAN
4.57
23. Journey Medical DERM
3.78
24. Ayr Wellness 3KJB.F
3.71
25. Perrigo PRGO
3.65
26. Teva Pharmaceutical Industries TEVA
3.61
27. Taro Pharmaceutical Industries TARO
3.55
28. Bausch Health Companies BHC
3.52
29. Cronos Group CRON
3.23
30. Ironwood Pharmaceuticals IRWD
3.1
31. Theratechnologies THTX
2.98
32. Procaps Group PROC
2.59
33. Zynerba Pharmaceuticals ZYNE
2.47
34. Solid Biosciences SLDB
2.44
35. Embecta EMBC
2.4
36. Jupiter Wellness JUPW
2.39
37. Amneal Pharmaceuticals AMRX
2.31
38. Societal CDMO SCTL
2.21
39. Eagle Pharmaceuticals EGRX
2.19
40. SCYNEXIS SCYX
2.15
41. Relmada Therapeutics RLMD
2.06
42. Emergent BioSolutions EBS
1.94
43. Clever Leaves Holdings CLVR
1.87
44. Alpha Teknova TKNO
1.85
45. OptiNose OPTN
1.83
46. Tilray Brands TLRY
1.8
47. Ascend Wellness Holdings AAWH
1.77
48. Biofrontera BFRI
1.74
49. Flora Growth FLGC
1.63
50. Universe Pharmaceuticals UPC
1.61
51. Evolus EOLS
1.44
52. ANI Pharmaceuticals ANIP
1.3
53. Regencell Bioscience Holdings RGC
0.83
54. Harrow Health HROW
0.54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.